Akerna to Announce Financial Results for the Second Quarter of 2022 on August 10, 2022
DENVER, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Akerna (NASDAQ:KERN), a leading enterprise software company and developer of the most comprehensive technology infrastructure, ecosystem, and compliance engine powering the global cannabis industry, today announced that management will report its financial results for the second quarter ended June 30, 2022, after the close of trading on Wednesday, August 10, 2022. The company will subsequently host a conference call at 8:30 AM ET the following day, Thursday, August 11, consisting of prepared remarks by management and a live Q&A Session.
Any interested parties who would like to participate in the call by phone are encouraged to dial Toll-Free: 888-999-5318, or Toll / International: 848-280-6460 at least 5 minutes prior to the start of the call. The Conference ID is 4956626. The conference call will also be available via a live, listen-only webcast and can be accessed over the internet through the Investor Relations section of Akerna's website, https://ir.akerna.com/.
To be included on the Company's email alerts list, please sign up at https://ir.akerna.com/news-events/email-alerts.
About Akerna
Akerna (NASDAQ:KERN) is an enterprise SaaS company focused on compliantly serving the cannabis, hemp, and CBD industry. First launched in 2010, Akerna has tracked more than $20 billion in cannabis sales to date and is the first cannabis software company listed on Nasdaq. Using connected data and information to propel the cannabis industry forward, Akerna empowers businesses, governments, patients, and consumers to make smart decisions.
The Company's cornerstone technology, MJ Platform, the world's leading infrastructure as a service platform, powers retailers, manufacturers, brands, distributors, and cultivators. Akerna also offers a complete suite of professional consulting services and data analytics for businesses as well as solo sciences, Leaf Data Systems, Trellis, Ample Organics, Viridian Sciences and 365 Cannabis.
For more information, visit https://www.akerna.com/.
Forward Looking Statements
Certain statements made in this release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. Such forward-looking statements include but are not limited to statements regarding the intended date on which we will announce results for Q2 2022 and the timing for management's conference call in relation to our quarterly results. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of significant known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside Akerna's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect actual results or outcomes, include risks and uncertainties disclosed from time to time in Akerna's filings with the U.S. Securities and Exchange Commission, including those under the heading "Risk Factors" in the Company's latest annual report on Form 10-K filed on March 31, 2022 and in its subsequent reports. You are cautioned not to place undue reliance on forward-looking statements. All information herein speaks only as of the date hereof, in the case of information about Akerna, or the date of such information, in the case of information from persons other than Akerna. Akerna undertakes no duty to update or revise the information contained herein.
Contacts:
Akerna
Meghan Shine, Head of Strategic Operations & Communications
303.917.6179
[email protected]
Core IR
Peter Seltzberg, SVP Capital Markets and Advisory
516.419.9915
[email protected]
